The EU Biotech and Life Sciences Alliance is an MEP interest group founded to gather members of the European Parliament interested in biotechnology across sectors.
The EU Biotech Mandate: A Path to Global Leadership and Resilience
The 2024–2029 EU mandate will be critical to securing global leadership in biotechnology and life sciences in all sectors, maximising impact from a broad cluster of EC legislation and strategies, led by the Biotech Act.
This will boost competitiveness, improve healthcare for citizens, strengthen resilience of supply chains, and lead on a sustainability transition. The EU must build on its significant strength in biotech and life sciences and take bold, coordinated action.
Group Objectives
The MEP Interest Group will support EU ambitions for global prosperity, resilience and leadership through cross-party dialogue and informed policymaking.
01
Facilitating discussion and knowledge exchange between policymakers and stakeholders to enhance policy coherence across legislation and make the EU legislative landscape simpler and faster for innovators through informed policymaking.
02
Bringing together stakeholders from across the biotech ecosystem, from academia, industry and citizens, to improve collaboration and innovation maturation in strategic applications for the EU, including with representatives of other strategic technologies such as AI.
03
Connecting EU policymakers with biotech innovators from their own constituencies, to ensure that policy development reflects regional strengths and ambitions.
How we work: A series of priorities
Secretariat & Funding
EuropaBio, the European association for bioindustries, supports the Group’s secretariat.
The secretariat for the group is delivered by APCO, contact secretariat@biolifesciences.eu.
